(Q30557216)

English

The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study (English)

1 reference

Europe PubMed Central

19 August 2017

multicenter clinical trial

0 references

Duchenne muscular dystrophy

1 reference

based on heuristic

inferred from title

Craig M. McDonald

object named as

Craig M McDonald

1

0 references

author name string

Erik K Henricson

2

1 reference

Europe PubMed Central

19 August 2017

R Ted Abresch

3

1 reference

Europe PubMed Central

19 August 2017

Julaine Florence

4

1 reference

Europe PubMed Central

19 August 2017

Michelle Eagle

5

1 reference

Europe PubMed Central

19 August 2017

Eduard Gappmaier

6

1 reference

Europe PubMed Central

19 August 2017

Allan M Glanzman

7

1 reference

Europe PubMed Central

19 August 2017

PTC124-GD-007-DMD Study Group

8

1 reference

Europe PubMed Central

19 August 2017

Robert Spiegel

9

1 reference

Europe PubMed Central

19 August 2017

Jay Barth

10

1 reference

Europe PubMed Central

19 August 2017

Gary Elfring

11

1 reference

Europe PubMed Central

19 August 2017

Allen Reha

12

1 reference

Europe PubMed Central

19 August 2017

Stuart W Peltz

13

1 reference

Europe PubMed Central

19 August 2017

publication date

17 July 2013

1 reference

Europe PubMed Central

19 August 2017

Muscle and Nerve

1 reference

Europe PubMed Central

19 August 2017

48

1 reference

Europe PubMed Central

19 August 2017

3

1 reference

Europe PubMed Central

19 August 2017

357-368

1 reference

Europe PubMed Central

19 August 2017

The 6-Minute Walk Test and Person-Reported Outcomes in Boys with Duchenne Muscular Dystrophy and Typically Developing Controls: Longitudinal Comparisons and Clinically-Meaningful Changes Over One Year

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

The cooperative international neuromuscular research group Duchenne natural history study--a longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods used

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

The role of the neuromuscular medicine and physiatry specialists in the multidisciplinary management of neuromuscular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Percent-predicted 6-minute walk distance in duchenne muscular dystrophy to account for maturational influences.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Systemic administration of PRO051 in Duchenne's muscular dystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Classification of the gait patterns of boys with Duchenne muscular dystrophy and their relationship to function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Relationship between clinical outcome measures and parent proxy reports of health-related quality of life in ambulatory children with Duchenne muscular dystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

A randomized study of alglucosidase alfa in late-onset Pompe's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years - four states, 2007.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

PTC124 targets genetic disorders caused by nonsense mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

How young can children reliably and validly self-report their health-related quality of life?: an analysis of 8,591 children across age subgroups with the PedsQL 4.0 Generic Core Scales

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Physical performance testing in mucopolysaccharidosis I: a pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

The PedsQL™* 4.0 as a Pediatric Population Health Measure: Feasibility, Reliability, and Validity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Longitudinal data analysis: an application to construction of a natural history profile of Duchenne muscular dystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Minimal clinically important difference module: summary, recommendations, and research agenda.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Profiles of neuromuscular diseases. Duchenne muscular dystrophy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Clinical investigation in duchenne dystrophy: 2. Determination of the ?power? of therapeutic trials based on the natural history

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Measurement of health status. Ascertaining the minimal clinically important difference

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

The energy expenditure index: a method to quantitate and compare walking energy expenditure for children and adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Measurement of isometric force in children with and without Duchenne's muscular dystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

20 June 2018

Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23905

21 January 2018

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23905

21 January 2018

The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23905

21 January 2018

The 6-minute walk test in Duchenne/Becker muscular dystrophy: longitudinal observations

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23905

21 January 2018

Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study.

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23905

21 January 2018

The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23905

21 January 2018

Defining clinically meaningful change in health-related quality of life.

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23905

21 January 2018

Intermittent prednisone therapy in Duchenne muscular dystrophy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23905

21 January 2018

Prednisolone in Duchenne muscular dystrophy with imminent loss of ambulation.

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23905

21 January 2018

PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23905

21 January 2018

The PedsQL 4.0 Generic Core Scales: sensitivity, responsiveness, and impact on clinical decision-making

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23905

21 January 2018

Six-minute walk test in children and adolescents.

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23905

21 January 2018

Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference.

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23905

21 January 2018

North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23905

21 January 2018

Profiles of neuromuscular diseases. Design of the protocol.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

26 November 2018

Effect sizes for interpreting changes in health status.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826053

26 November 2018

Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reference values of maximum isometric muscle force obtained in 270 children aged 4–16 years by hand-held dynamometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Small changes in six-minute walk distance are important in diffuse parenchymal lung disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combining distribution- and anchor-based approaches to determine minimally important differences: the FACIT experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional ability and muscle force in healthy children and ambulant Duchenne muscular dystrophy patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Muscle pathology and clinical measures of disability in children with cerebral palsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The assisted 6-minute cycling test to assess endurance in children with a neuromuscular disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance: A statistical approach to defining meaningful change in psychotherapy research

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leisure-time physical activity among US adults. Results from the Third National Health and Nutrition Examination Survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Energy cost of walking in normal children and in those with cerebral palsy: comparison of heart rate and oxygen uptake

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence-based path to newborn screening for Duchenne muscular dystrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reliability of quantitative muscle testing in healthy children and in children with Duchenne muscular dystrophy using a hand-held dynamometer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An integrated method to determine meaningful changes in health-related quality of life

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Energy expenditure index of walking for normal children and for children with cerebral palsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bosentan therapy for pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determining the minimal clinically important difference for the six-minute walk test and the 200-meter fast-walk test during cardiac rehabilitation program in coronary artery disease patients after acute coronary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trial in Duchenne dystrophy. I. The design of the protocol

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interpretation of treatment changes in 6-minute walk distance in patients with COPD

1 reference

https://pubmed.ncbi.nlm.nih.gov/23674289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/MUS.23905

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30557216&oldid=1548621008"